Refine by
Health Based Articles & Analysis
77 news found
“We are raising the bar for how cloud-based health data should be managed and protected,” said Daan van Well, Chief Legal and Regulatory Officer of SOPHiA GENETICS. ...
Canaquest Medical Corp (OTC PINK:CANQF) (the "Company" or "CanaQuest"), a clinical-stage life sciences company focused on drug discovery and development of next-generation targeted cannabinoid therapeutics for the central nervous system (CNS), today announced that it has been awarded the Best Global Medical Cannabinoid Development Company 2023, in its eighth annual Healthcare and Pharmaceutical ...
” Lifespin is working to build new precision medicine tools based on quantitative metabolic profiles and proprietary algorithms to assist in the early detection of diseases and monitoring the efficacy of health treatments. ...
To date, the company has raised $195M in funding and is rapidly growing in pursuit of its mission to use computer vision-based technology to reduce disparities in healthcare. Iterative Health has partnered with multiple clinical research sites and continues to expand its impact and reach through this relationship with Gastro Health. ...
(FREMONT, CA) December 5, 2022 – THINK Surgical, a technology innovator developing orthopedic surgical robots, today announced a collaboration with UK based digital health company, Definition Health. The companies will jointly develop a seamless, web-based, connected care solution to enhance the surgical planning ...
Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics® as well as rationally designed Synergistic Synbiotics®. The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other ...
“Our new partnership with Dante Genomics will make it easier for women to access exciting new DNA testing opportunities that will provide greater health insights. Everyone deserves to have individualised understanding of their health DNA testing affords. ...
” Oxford Brain Diagnostics Ltd is rethinking how brain health is assessed and managed. Founded in neuropathological and neuroimaging expertise, the company’s patented Cortical Disarray Measurement (CDM®) technology uses MRI brain scan data to support early and differential diagnosis, track progression, and predict the decline of neurodegenerative diseases. Oxford ...
Enalare Therapeutics Inc., a biopharmaceutical company dedicated to developing novel therapies for patients suffering from life threatening critical care conditions and community based health emergencies, announced today that the U.S. Food and Drug Administration (FDA) has granted its lead compound, ENA-001, Orphan Drug Designation for the treatment of Apnea of ...
” Lifespin (www.lifespin.health) is a deep data company that maps human health based on snapshots of metabolic states. Lifespin has standardized the baseline for human health to detect distinct deviations in the human metabolism caused by diseases. ...
Since then, ANGANY’s platform has attracted significant attention from major players in the Pharma and Animal Health markets. Based on this interest and following a successful Series A round of $ 15 million backed exclusively by private investors, ANGANY is currently preparing a Series B investment round of $ 35 million to finance upcoming clinical ...
The Total Brain platform helps more than one million individuals improve overall mental health and brain performance using several semi-quantitative functional methods. ...
Because enzymes have such a significant impact on human health, research on enzyme-based drugs has emerged as a focus in recent times. ...
Debiopharm Innovation Fund (www.debiopharm.com/digital-health/), the strategic digital health investment arm of Debiopharm, announced their co-investment in Fosanis, a Berlin-based digital health company developing Mika, Germany’s first prescription DTx across all oncology indications. ...
Transitioning from his role as a 4D Path advisory board member, world-renowned cancer oncologist, health consultant, and entrepreneur Dr. Teich will now serve as 4D Path’s Chief Global Strategist. ...
Microbiome-based ingredient company Synbiotic Health announces that Kevin Hooper has joined the company as Director of Business Development. ...
The CB Insights research team selected the Digital Health 150 from a pool of over 11,000 companies; Exo was chosen based on several factors, including data submitted, business models and momentum in the market. ...
ByExo
Neurovalens, a global leader of neuro-technology products, is embarking on the development of a device for the treatment of obesity with £1m support from Invest NI. The technology is based on the neuro stimulation of specific areas of the brain responsible for influencing appetite and cravings. The company specialises in combining neuroscience and technology to tackle ...
Microbiome-based ingredient company Synbiotic Health is pleased to announce the appointment of Erin Vyhlidal as Controller and Vice President, Corporate Finance. ...
Indianapolis-based Community Health Network is expected to be the first health system to pilot candidate alerts. ...